Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
CareDx
4397
CareDx
Health
Fitness
Health and Wellness
Health Care
Technology
Biotechnology
AlloMap is a way to non-invasively test cardiac transplant patients for their risk of acute cellular rejection, graft failure, and death.
Suggest edits
Founded
2000
Raised
$150M
Follow us
Companies in the same industry
Elysium Health
Deep Longevity
AbiogeniX
Iagnosis
Punctil
LifeTime
Jessica Anderson
Every Mother
QorQl
Immunity Project
Alexa global traffic share
Twitter followers
Overview
Funding
8
Add info
Latest funding
Show all
$25,000,000
Post-IPO debt - 2017
$22,170,000
Post-IPO equity - 2016
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
Pulse 2.0
CareDx Stock (CDNA): Why The Price Surged Today
neurons.AI
CareDx Advances Artificial Intelligence in Transplantation
FinSMEs
CareDx Buys XynManagement
$25,000,000
Post-IPO debt
GlobeNewswire News Room
CareDx Closes New $25 Million Debt Facility
